在胃肠道上部腺癌的长非编码RNA的发展和进展方面取得了研究进展
Haitao Wei1, Xiaojin Lin2, Ruirui Fang2
1Department of Thoracic Surgery, Huaihe Hospital, Henan University, No.8 Bao Bei Street, Gu Lou District, Kaifeng, 475099, Henan, China.
Discover oncology
|June 1, 2025
概括
长非编码RNAs (lncRNAs) 在调节上部胃肠腺癌方面至关重要. 这项研究探讨了它们作为潜在生物标志物和治疗点的作用,以改善癌症诊断和治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 上部胃肠道腺癌的发病率正在上升,潜伏的早期症状导致晚期诊断和患者预后不佳.
- 识别新的生物标志物和治疗点对于改善这些癌症的结果至关重要.
- 长非编码RNAs (lncRNAs) 参与癌症的发展,调节癌症的增殖,转移和亡抵抗.
研究的目的:
- 系统地研究lncRNAs在上部胃肠道腺癌发生中的功能作用.
- 要总结 lncRNAs 对上部胃肠腺癌进展的已知影响.
- 探索 lncRNAs 作为早期诊断和治疗的潜在生物标志物和治疗点.
主要方法:
- 在上部胃肠腺癌中对lncRNA功能的系统审查和分析.
- 探索瘤进展中的差异性lncRNA表达模式.
- 研究由lncRNAs调节的相关信号通路.
主要成果:
- lncRNAs在调节上部胃肠腺癌的恶性过程中发挥着重要作用.
- lncRNAs的差异表达与瘤进展相关.
- lncRNAs参与了与癌症发展相关的关键信号通路.
结论:
- lncRNAs作为生物标志物具有显著的潜力,用于早期诊断上部胃肠腺癌.
- lncRNAs代表了新型治疗策略的有希望的治疗点.
- 对lncRNA的进一步研究将为临床管理提供至关重要的理论支持.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
659
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.9K
相关概念视频
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Non-LTR Retrotransposons
11.9K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K
The Nucleolus
9.2K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.2K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
